24 Oct Feds Warn Another Florida CBD Company Not to Make Medical Claims
The US Federal Trade Commission and the US Food and Drug Administration (FDA) sent a warning letter to Naples Florida-based Rooted Apothecary on Oct. 10th that their products are considered “misbranded drugs” due to claims that their CBD products can treat medical conditions and then selling them online.
THE FTC and FDA claim the company made the claim that their CBD products are an effective treatment for the following:
- Attention-deficit/hyperactivity disorder (ADHD)
The feds also noted that they were concerned about the company marketing “unapproved new drugs for uses in infants and children”.
Only one CBD product has been approved by the FDA for sale in the US. That is Epidiolex by GW Pharmaceuticals and it was approved for only certain types of epilepsy. The federal government also holds a patent on CBD for its medical use. However, CBD products that aren’t sold under the FDA are not allowed to make any medical claims. As you can see, they are certainly enforcing it.